Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats

World Journal of Gastroenterology

Volumn 12, Issue 2, 2006, Pages 265-270

  Lin, Wen Chuan ^a   Lin, Wei Lii ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carbon tetrachloride; Ganoderma lucidum; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; GANODERMA LUCIDUM EXTRACT; GLOBULIN; HYDROXYPROLINE; MALONALDEHYDE; MESSENGER RNA; METHIONINE ADENOSYLTRANSFERASE; SCAVENGER; TRANSFORMING GROWTH FACTOR BETA;

ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG RESPONSE; FEEDING; HISTOCHEMISTRY; LIVER; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RANDOMIZATION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN WEIGHT; TISSUE DISTRIBUTION;

EID: 33644779112     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i2.265     Document Type: Article

References (40)

1. Hsu HY. Oriental Materia. Medica. Long Beach CA: Oriental Healing Arts Institute, 1986: 640-641
2. Lin JM, Lin CC, Chiu HT, Yang JJ, Lee SG. Evaluation of the anti- inflammatory and liver-protective effects of anoectochilus formosanus, ganoderma lucidum and gynostemma pentaphyllum in rats. Am J Chin Med 1993; 21:59-69
3. Lin JM, Lin CC, Chen MF, Ujiie T, Takada A. Radical scaveng-er and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neojaponicum. J Ethnopharmacol 1995; 47: 33-41
4. Liu G, Bao T, Wei H, Song,, Z. [Some pharmacological actions of Ganoderma lucidum and G. japonicum (FR) Llyod on mouse liver (author's transl)] Yao Xue Xue Bao 1979; 14: 284-287
5. Kim DH, Shim SB, Kim NJ, Jang IS. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull 1999; 22: 162-164
6. Wang MY, Liu Q, Che QM, Lin ZB. Effects of triterpenoids from Ganderma lucidum (Leyss. ex Fr.) Karst on three different experimental liver injury models in mice. Acta Pharm Sin 2000; 35: 326-329
7. Park EJ, Ko G, Kim J, Sohn DH. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull 1997; 20: 417-420
8. Alcolado R, Arthur MJ, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci (Lond) 1997; 92: 103-112
9. Gebhardt R. Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment. Phytother Res 2002; 16: 368-72
10. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents. Biochem J 1971; 123: 823-8
11. De Pomerai DI, Pritchard DJ, Clayton RM. Biochemical and immunological studies of lentoid formation in cultures of embryonic chick neural retina and day-old chick lens epithelium. Dev Biol 1977; 60: 416-27
12. Kim KC, Kim IG. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. Int J Mol Med 1999; 4: 273-277
13. Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, Surh YJ. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 2001; 15: 245-249
14. Zhu M, Chang Q, Wong LK, Chong FS, Li RC. Triterpene antioxidant froms ganoderma lucidum. Phytother Res 1999; 13: 529-531
15. Wang MY, Liu Q, Che QM, Lin ZB. Effects of total triterpenoids extract from Ganoderma lucidum (Curt.: Fr.) P. Karst. (Reishi mushroom) on experimental liver injury models induced by carbon tetrachloride or d-galactosamine in mice. Int J Med Mushrooms 2002; 4: 337-342
16. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358
18. NEUMAN RE, LOGAN MA. The determination of hydroxyproline. J Biol Chem 1950; 184: 299-306
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
20. Manoucheri M, Karunaratne HB. The role of imaging techniques in stress testing. Prim Care 1994; 21: 535-55
21. Rozen S, Skaletsky HJ. Primer3. Code available at http:// www.genome.wi.mit.edu/genome-software/other/primer3.html
22. Ruwart MJ, Wilkinson KF, Rush BD, Vidmar TJ, Peters KM, Henley KS, Appelman HD, Kim KY, Schuppan D, Hahn EG. T The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 1989; 10: 801-806
23. Mato JM, Corrales FJ, Lu SC, Avila MA. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J 2002; 16: 15-26
24. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 1997; 73: 265-280
25. Avila MA, Mingorance J, Martinez-Chantar ML, Casado M, Martin-Sanz P, Bosca L, Mato JM. Regulation of rat liver S-adenosylmethionine synthetase during septic shock: role of nitric oxide. Hepatology 1997; 25: 391-6
26. Frago LM, Gimenez; A, Rodriguez EN, Varela-Nieto I. Pattern of methionine adenosyltransferase isoenzyme expression during rat liver regeneration after partial hepatectomy. FEBS Lett 1998; 426: 305-308
27. Chamberlin ME, Ubagai T, Mudd SH, Wilson WG, Leonard JV, Chou JY. Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J Clin Invest 1996; 98: 1021-7
28. Paneda C, Gorospe I, Herrera B, Nakamura T, Fabregat I, Varela-Nieto I. Liver cell proliferation requires methionine adenosyltransferase 2A mRNA up-regulation. Hepatology 2002; 35: 1381-1391
29. Podolsky DK, Isselbacher KJ. Derangements of hepatic metabolism, In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdor RG, Martin JB, Fauci AS, Root RK. Harrison's Principle of Internal Medicine. 14th ed. New York: McGrawHill, 1998: 1677-1672
30. Vandenberghe J. Hepatotoxicology: mechanisms of liver toxicity and methodological aspects. In: Niesink RJM, De Vries J, Hollinger MA. Toxicology: Principle and Applications. New York: CRC Press, 1996: 703-723
31. Bissell DM, Friedman SL, Maher JJ, Roll FJ. Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology 1990; 11: 488-498
32. Hanauske-Abel HM. Fibrosis of the liver: representative molecular elements and their emerging role as anti-fibrotic targets. In: Zakim D, Boyer TD. Hepatology: A Textbook of Liver Disease. 4th ed. Philadelphia: W.B. Saunders, 2003: 347-394
33. Yamada Y, Fausto N. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 1998; 152: 1577-89
34. Perez Tamayo R. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology 1983; 3: 112-120
35. Gill MA, Kircbain WR. Alcoholic liver disease. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Poser LM. Pharmacotherapy: A Pathophysiologic Approach. third ed. Stamford: Appleton & Lange,1997: 785-800
36. Kocher O, Kennedy SP, Madri J A. Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance. Am J Pathol 1990; 137: 1509-1524
37. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal hpocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992; 89: 19-27
38. De Bleser PJ, Niki T, Rogiers V, Geerts A. Transforminggrowth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol 1997; 26: 886-893
39. Chen WX, Li YM, Yu CH, Cai WM, Zheng M, Chen F. Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World J Gastroenterol 2002; 8: 379-381
40. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-bate in hepatic fibrosis. Front Biosci 2002; 7: d793-807